Riverhead Capital Management’s Usana Health Sciences USNA Stock Holding History

Riverhead Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$89K	Buy	+1,300	New	+$87.3K	﹤0.01%	1356

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverhead Capital Management's USNA Position: Q3 2019 in Review

Riverhead Capital Management opened a new position in Usana Health Sciences (USNA) in Q3 2019: 1,300 shares worth $89K. The stake represents ﹤0.01% of the portfolio and ranks #1356 among its holdings.

169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

Riverhead Capital Management held 1,300 shares of Usana Health Sciences worth $89K as of Q3 2019.
Usana Health Sciences was a new Riverhead Capital Management position in Q3 2019.
Usana Health Sciences made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1356 holding.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.